methylbufotenin has been researched along with psilocin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gerasimov, M; Kurrasch-Orbaugh, DM; Marona-Lewicka, D; Nichols, DE; Qandil, AM | 1 |
| Kargbo, RB | 2 |
3 other study(ies) available for methylbufotenin and psilocin
| Article | Year |
|---|---|
Further studies on oxygenated tryptamines with LSD-like activity incorporating a chiral pyrrolidine moiety into the side chain.
Topics: Animals; Binding, Competitive; Discrimination Learning; Frontal Lobe; In Vitro Techniques; Indoles; Lysergic Acid Diethylamide; Male; Pyrrolidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Stereoisomerism; Structure-Activity Relationship; Tryptamines | 1999 |
The Psychedelic Renaissance: Addressing Potential Adverse Effects in a Therapeutic Setting.
Topics: | 2021 |
Improved Metabolically Stable 5-HT Receptor Modulators and the Development of New Antidepressants.
Topics: | 2022 |